Altivera Medical Acquires Zynex Following Bankruptcy Resolution

Zevra Therapeutics Acquires Acer Therapeutics

November 20, 2023

Pharmaceuticals

Zevra Therapeutics completed the acquisition of Acer Therapeutics in a stock-and-contingent-value-rights transaction, bringing the FDA-approved product OLPRUVA and clinical-stage candidate EDSIVO into Zevra's portfolio and transitioning Zevra to a commercial-stage rare disease company. The deal included Zevra's purchase of Acer's senior secured debt and issuance of approximately 2.96 million shares plus CVRs (up to $76 million), and was followed by a registered direct offering to a healthcare-focused investment fund.

Arterex (Investindustrial-backed) Acquires NextPhase Medical Devices

July 17, 2023

Medical Devices

Arterex (Medical Device, Inc.), an Investindustrial-backed medical device contract manufacturer, has acquired NextPhase Medical Devices from Kidd & Company, LLC. The deal expands Arterex’s global multi-capability platform — nearly doubling the group’s scale and adding complementary design, engineering and complex electromechanical and implantable device manufacturing capabilities across North America and internationally.

Veranex Acquires Fusion Biotec

December 13, 2022

Medical Devices

Veranex has acquired Fusion Biotec, a Southern California design and engineering firm specializing in complex electro-mechanical diagnostic instrumentation and medical devices. The acquisition brings Fusion's 15,000-square-foot facility and 45+ engineering staff into Veranex's Product Design & Engineering capabilities, expanding Veranex's diagnostic/IVD development, software/firmware reuse and Southern California footprint; financial terms were not disclosed.

Accelmed Partners II and Lauxera Capital Invest in Veranex

November 14, 2022

Healthcare Services

Veranex has received strategic growth investments from Accelmed Partners II and Lauxera Capital Partners, joining existing investor Summit Partners, which retains majority ownership. The investments — terms undisclosed — will support Veranex’s continued global expansion and development of its integrated, tech‑enabled medical technology product development services; Uri Geiger (Accelmed) and Samuel Levy (Lauxera) joined Veranex’s board.

Zynex Acquires Kestrel Labs

December 22, 2021

Medical Devices

Zynex, Inc. acquired 100% of Kestrel Labs, Inc. in a transaction that closed December 22, 2021 for approximately $31.0 million (about $16.0 million cash financed by Bank of America and $15.0 million in Zynex common stock). Kestrel Labs develops laser-based, noninvasive patient monitoring devices (NiCO CO‑Oximeter and HemeOx) that are not yet FDA-cleared; Zynex said it will integrate the technologies into its monitoring portfolio and pursue regulatory clearance and commercialization.

Veranex (backed by Summit Partners) Forms Platform and Acquires Ximedica, Quartesian, and Boston Healthcare Associates

June 16, 2021

Healthcare Services

Veranex, formed in partnership with growth investor Summit Partners, launched a concept-to-commercialization medtech services platform and acquired three complementary companies: Ximedica, Quartesian, and Boston Healthcare Associates. The combined business brings design and engineering, clinical data, regulatory, and market-access/HEOR capabilities together to create an integrated, global medtech service provider.